Medical Xpress July 12, 2024
Researchers from University of California San Diego have found that two of the most frequently administered stem cell therapies, which are often used interchangeably, actually contain completely different types of cells. The results challenge the current “one-cell-cures-all” paradigm in orthopedic stem cell therapeutics and highlight the need for more informed and rigorous characterization of injectable stem cell therapies before they are marketed for use in patients.
The researchers analyzed cell populations of autologous bone marrow aspirate concentrate (BMAC) and adipose-derived stromal vascular fraction (ADSVF) collected from the same subjects. The study was published July 12, 2024 in Science Advances.
These two therapies have many similarities: both are injectable therapies derived from a patient’s own cells—bone marrow in BMAC and adipose...
Today's Sponsors
Today's Sponsor